This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hedgehog, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hye-Mi Ahn: Innovator in Monoclonal Antibody Research
Introduction
Hye-Mi Ahn is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic agents targeting specific receptors.
Latest Patents
Hye-Mi Ahn holds 1 patent for her invention titled "Endothelin receptor type A activity regulating antibody." This invention relates to a monoclonal antibody or a fragment that specifically recognizes and binds to the extracellular domain of the endothelin receptor type A. The monoclonal antibody is designed for use as a therapeutic agent for conditions such as hypertension or cancer associated with endothelin receptor type A.
Career Highlights
Hye-Mi Ahn is currently employed at Hedgehog, Inc., where she continues to advance her research in antibody development. Her work has the potential to impact the treatment of various diseases significantly.
Collaborations
Hye-Mi collaborates with notable colleagues, including Sang Taek Jung and Yeon Gyu Yu, who contribute to her research efforts and innovations.
Conclusion
Hye-Mi Ahn's work in monoclonal antibody research exemplifies the innovative spirit of modern science. Her contributions are paving the way for new therapeutic options in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile